SG11201402027PA - Methods for treating gout in patient subpopulations - Google Patents

Methods for treating gout in patient subpopulations

Info

Publication number
SG11201402027PA
SG11201402027PA SG11201402027PA SG11201402027PA SG11201402027PA SG 11201402027P A SG11201402027P A SG 11201402027PA SG 11201402027P A SG11201402027P A SG 11201402027PA SG 11201402027P A SG11201402027P A SG 11201402027PA SG 11201402027P A SG11201402027P A SG 11201402027PA
Authority
SG
Singapore
Prior art keywords
methods
treating gout
patient subpopulations
subpopulations
patient
Prior art date
Application number
SG11201402027PA
Other languages
English (en)
Inventor
Gopal Chandra Saha
Brian K Roberts
Brian Edward Lavan
Charles A Mcwherter
Original Assignee
Metabolex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metabolex Inc filed Critical Metabolex Inc
Publication of SG11201402027PA publication Critical patent/SG11201402027PA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11201402027PA 2011-11-04 2011-11-04 Methods for treating gout in patient subpopulations SG11201402027PA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/059425 WO2013066352A1 (en) 2011-11-04 2011-11-04 Methods for treating gout in patient subpopulations

Publications (1)

Publication Number Publication Date
SG11201402027PA true SG11201402027PA (en) 2014-09-26

Family

ID=48192536

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201402027PA SG11201402027PA (en) 2011-11-04 2011-11-04 Methods for treating gout in patient subpopulations

Country Status (14)

Country Link
EP (1) EP2775835A4 (enExample)
JP (1) JP6047172B2 (enExample)
KR (1) KR101848122B1 (enExample)
CN (1) CN104066323A (enExample)
AU (1) AU2011380509B2 (enExample)
BR (1) BR112014010693A2 (enExample)
CA (1) CA2859689C (enExample)
CL (1) CL2014001156A1 (enExample)
IL (1) IL232385A (enExample)
MX (1) MX354846B (enExample)
NZ (1) NZ624714A (enExample)
SG (1) SG11201402027PA (enExample)
WO (1) WO2013066352A1 (enExample)
ZA (1) ZA201403574B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2836209A4 (en) * 2012-04-13 2015-11-25 Cymabay Therapeutics Inc METHOD FOR THE TREATMENT OF HYPERURICEMIA IN PATIENTS WITH A GOG THROUGH HALOFENATE OR HALOFENIC ACID AND AN INFLAMMATORY INHIBITOR
CN104068288B (zh) * 2014-07-25 2016-08-24 许伟琦 一种防尿路结石的饲料添加剂
CN105920022A (zh) * 2016-05-12 2016-09-07 成都易创思生物科技有限公司 一种抗痛风药物复方制剂
WO2019082335A1 (ja) * 2017-10-26 2019-05-02 大塚製薬株式会社 イノシトールリン酸含有組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4250191A (en) * 1978-11-30 1981-02-10 Edwards K David Preventing renal failure
US6262118B1 (en) * 1999-06-04 2001-07-17 Metabolex, Inc. Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia
CN103058944B (zh) * 2007-11-27 2015-08-05 亚德生化公司 调节血液尿酸水平的化合物

Also Published As

Publication number Publication date
EP2775835A1 (en) 2014-09-17
CN104066323A (zh) 2014-09-24
IL232385A (en) 2017-10-31
IL232385A0 (en) 2014-06-30
MX354846B (es) 2018-03-22
NZ624714A (en) 2016-01-29
CA2859689A1 (en) 2013-05-10
BR112014010693A2 (pt) 2020-11-10
CL2014001156A1 (es) 2015-01-16
ZA201403574B (en) 2015-11-25
KR101848122B1 (ko) 2018-04-11
JP6047172B2 (ja) 2016-12-21
KR20140123927A (ko) 2014-10-23
MX2014005399A (es) 2015-04-08
WO2013066352A1 (en) 2013-05-10
AU2011380509A1 (en) 2014-05-29
EP2775835A4 (en) 2015-07-29
CA2859689C (en) 2018-05-22
JP2014532759A (ja) 2014-12-08
AU2011380509B2 (en) 2016-05-19

Similar Documents

Publication Publication Date Title
HUE045988T2 (hu) Csúsztatható berendezés hõterápiás kezeléshez
PL3412687T3 (pl) Sposoby leczenia dlbcl
EP2531625A4 (en) PROCESS FOR PROCESSING FRACTURE MATERIALS
ZA201208219B (en) Method for treating wasterwater
PL2735250T3 (pl) Urządzenie typu przesuwnego dla leczenia termo terapeutycznego
IL220594A0 (en) Treatment method
SG11201401981TA (en) Methods for treating gout flares
ZA201403574B (en) Methods for treating gout in patient subpopulations
ZA201308117B (en) Avian-based treatment
IL228744A0 (en) A method for treating diseases related to interferon alpha
GB201105523D0 (en) Treatment method
GB201121950D0 (en) Treatment process
EP2813798A4 (en) METHOD OF EXPLOSION TREATMENT
SG11201402309YA (en) Process for medical components and uses thereof
GB201102283D0 (en) Treatment
EP2768536A4 (en) METHOD OF TREATING TYPE I AND TYPE II DIABETES
GB201109796D0 (en) Treatment device
SG11201403180YA (en) Improvements in machining apparatus
GB201102267D0 (en) Treatment
GB201102268D0 (en) Treatment
GB201102270D0 (en) Treatment
GB201102263D0 (en) Treatment
GB201111247D0 (en) Treatment
GB201102271D0 (en) Treatment
GB201102272D0 (en) Treatment